H
A. Hamsath et al.
Special Topic
Synthesis
+
2-(Tetrahydro-2H-pyran-4-yl)cyclohexa-2,5-diene-1,4-dione (12),
2,5-Bis(tetrahydro-2H-pyran-4-yl)cyclohexa-2,5-diene-1,4-dione
(12-Bis-C2,C5) and 2,6-Bis(tetrahydro-2H-pyran-4-yl)cyclohexa-
2,5-diene-1,4-dione (12-Bis-C2-C6)
HRMS (ESI-TOF): calcd for
289.1256
C
20H17O2 [M+H]+ 289.1223 found
13-Bis-C2,C5
1H NMR (400 MHz, CDCl3): δ = 7.35–7.29 (m, 4H), 7.29–7.22 (m, 4H),
7.21–7.15 (m, 2H), 6.29 (s, 2H), 3.75 (s, 4H)
13C NMR (100 MHz, CDCl3), mixture of all three isomers: δ = 188.0,
187.8, 187.7, 187.3, 148.9, 148.7, 143.9, 137.8, 136.7, 136.6, 136.5,
133.5, 133.3, 129.5, 128.98, 128.97, 128.8, 128.7, 127.13, 127.11,
126.7, 35.6, 35.0, 32.0.
General procedure A was employed using 1,4-benzoquinone (22 mg,
0.2 mmol) and tetrahydro-2H-pyran-4-carboxylic acid (56 mg, 0.4
mmol). The reaction afforded 12 (14.4 mg, 38%) as a yellow solid sep-
arated by silica gel chromatography (10% EtOAc in hexanes). The same
reaction also afforded a mixture of 12-Bis-C2,C5 and 12-Bis-C2,C6
(1:1) (9.5 mg, 17%) as a yellow oil.
General procedure B was employed using 1,4-benzoquinone (22 mg,
0.2 mmol) and tetrahydro-2H-pyran-4-carboxylic acid (56 mg, 0.4
mmol). The reaction afforded 12 (8.1 mg, 21%) as a yellow solid sepa-
rated by silica gel chromatography (10% EtOAc in hexanes).
HRMS (ESI-TOF): calcd for
289.1226
C
20H17O2 [M+H]+ 289.1223 found
+
13-Bis-C2,C6
1H NMR (400 MHz, CDCl3): δ = 7.35–7.29 (m, 4H), 7.29–7.22 (m, 4H),
7.21–7.15 (m, 2H), 6.35 (t, J = 1.6 Hz, 2H), 3.71 (d, J = 1.2 Hz, 4H)
13C NMR (100 MHz, CDCl3), mixture of all three isomers: δ = 188.0,
187.8, 187.7, 187.3, 148.9, 148.7, 143.9, 137.8, 136.7, 136.6, 136.5,
133.5, 133.3, 129.5, 128.98, 128.97, 128.8, 128.7, 127.13, 127.11,
126.7, 35.6, 35.0, 32.0.
Compound 12
1H NMR (400 MHz, CDCl3): δ = 6.79–6.70 (m, 2 H), 6.52 (dd, J = 2.3, 1.2
Hz, 1 H), 4.05 (dd, J = 11.6, 4.4 Hz, 2 H), 3.53 (td, J = 11.8, 2.1 Hz, 2 H),
3.01–2.90 (m, 1 H), 1.72–1.64 (m, 2 H), 1.56 (ddd, J = 25.1, 12.5, 4.4
Hz, 2 H).
13C NMR (100 MHz, CDCl3): δ = 187.9, 187.0, 152.0, 137.1, 136.2,
131.3, 67.9, 34.0, 31.6.
+
HRMS (ESI-TOF): calcd for
289.1247
C
20H17O2 [M+H]+ 289.1223 found
HRMS (ESI-TOF): m/z [M + H]+ calcd for C11H14O3+: 193.0859; found:
193.0857.
General Kinetic Procedures
To a vial containing a stir bar was added benzoquinone (44 mg, 0.4
mmol, 1 equiv), the radical precursor (0.8 mmol, 2 equiv) and the ox-
idant (0.8 mmol, 2 equiv) followed by dichloroethane (2 mL) and H2O
(1.8 mL). Tetrabutylbenzene (31 μL, 0.2 mmol) was then added as the
internal standard. The reaction mixture was stirred for 1 min without
catalyst. A 10 μL aliquot was then taken using a glass syringe and
transferred into a GC vial. The vial was then filled with EtOAc and
placed into the GCMS (Agilent Technologies 5975 Series MSD GCMS)
for analysis. A solution of AgNO3 (0.2 mL of a 0.4 M solution in H2O,
0.04 mmol) was added to the reaction in one portion. Aliquots (10 μL
) were taken for GCMS analysis every 20 min for the first hour, then
after 30 min for the second hour followed by one one-hour sample (3
hours), two two-hour samples (5 h and 7 h), a four-hour sample (11
h) and finally a twenty-four-hour sample. A previously prepared cali-
bration curve with benzoquinone and tert-butylbenzene as the stan-
dard along with their corresponding GC peak areas from each sample
produced the kinetic data in Scheme 3.
12-Bis-C2,C5 and 12-Bis-C2,C6
1H NMR (400 MHz, CDCl3): δ = 6.51 (s, 2 H), 6.48 (s, 2 H), 4.09–4.01
(m, 8 H), 3.56–3.53 (m, 8 H), 3.00–2.95 (m, 4 H), 1.69–1.66 (m, 8 H),
1.62–1.50 (m, 8 H).
13C NMR (100 MHz, CDCl3): δ = 188.2, 187.5, 186.5, 152.3, 151.6,
131.7, 130.9, 68.0, 66.0, 34.3, 33.8, 31.7, 31.6.
HRMS (ESI-TOF): m/z [M + H]+ calcd for C16H22O4+: 277.1434; found:
277.1419 and 277.1422, respectively.
2-Benzylcyclohexa-2,5-diene-1,4-dione (13), 2,5-Dibenzylcyclo-
hexa-2,5-diene-1,4-dione (13-Bis-C2,C5), 2,6-Dibenzylcyclohexa-
2,5-diene-1,4-dione (13-Bis-C2,C6) and 2,3-Dibenzylcyclohexa-
2,5-diene-1,4-dione (13-Bis-C2,C3)
General procedure A was employed using 1,4-benzoquinone (22 mg,
0.2 mmol) and 2-phenylacetic acid (54 mg, 0.4 mmol). The reaction
afforded 13 (20.5 mg, 52%) as a yellow oil separated by silica gel chro-
matography (5% EtOAc in hexanes). The data matches those previous-
ly reported.15 The same reaction also afforded a mixture of 13-Bis-
C2,C3, 13-Bis-C2,C5 and 13-Bis-C2,C6 (1:2:4) (7 mg, 12%) as a yellow
oil.
Parvaquone
2-Cyclohexylnaphthoquinone
To a vial containing a stir bar was added 1,4-naphthoquinone (316
mg, 2.0 mmol, 1 equiv), cyclohexanecarboxylic acid (512 mg, 4 mmol,
2 equiv) and (NH4)2S2O8 (912 mg, 4 mmol, 2 equiv) followed by di-
chloroethane (10 mL) and H2O (10 mL). AgNO3 (68 mg, 0.4 mmol, 20
mol%) was added in one portion. The reaction was capped with a
screw cap and stirred at room temperature for 24 h. Upon completion,
the reaction mixture was transferred into a separatory funnel con-
taining saturated NaHCO3 solution (20 mL). The aqueous phase was
extracted with EtOAc (3 × 3 mL) and the combined organic layers
were dried over MgSO4, filtered and carefully concentrated in vacuo.
The reaction afforded 2-cyclohexylnaphthoquinone (364 mg, 75%
yield) as a yellow solid separated by silica gel chromatography (5%
EtOAc in hexanes). The data matches those previously reported.15
General procedure B was employed using 1,4-benzoquinone (22 mg,
0.2 mmol) and benzoic acid (54 mg, 0.4 mmol). The reaction afforded
13 (12.3 mg, 31%) as a yellow solid separated by silica gel chromatog-
raphy (10% EtOAc in hexanes).
13-Bis-C2,C3
1H NMR (400 MHz, CDCl3): δ = 7.35–7.29 (m, 4H), 7.29–7.22 (m, 4H),
7.13–7.10 (m, 2H),6.78 (s, 2H), 3.93 (s, 4H)
13C NMR (100 MHz, CDCl3), mixture of all three isomers: δ = 188.0,
187.8, 187.7, 187.3, 148.9, 148.7, 143.9, 137.8, 136.7, 136.6, 136.5,
133.5, 133.3, 129.5, 128.98, 128.97, 128.8, 128.7, 127.13, 127.11,
126.7, 35.6, 35.0, 32.0.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2018, 50, A–I